Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.043 | 66 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.92579 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.77226 | 63 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.07448 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.97656 | 66 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.05398 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.05663 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.01483 | 66 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.01089 | 66 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.02948 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.99796 | 66 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.01431 | 66 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.02661 | 66 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.24497 | 69 |